GDF15 and type 2 diabetes mellitus: T2DM patients with ACS had significantly higher serum GDF-15 concentration compared to T2DM patients without ACS (1155.45 ± 321.01 ng/L vs. 841.63 ± 477.04 ng/L, P < 0.01).